Neurocrine Biosciences | Kapitalizacja Rynkowa



Market Capitalization Zmiana Data
AbbVie USD 341.09B 29.54B 2025-07
Acadia Pharmaceuticals USD 3.48B 714M 2025-07
Agios Pharmaceuticals USD 2.19B 496M 2025-07
ALKERMES USD 4.37B 349M 2025-07
Alnylam Pharmaceuticals USD 43.52B 8.39B 2025-07
Amgen USD 167.51B 27.54B 2025-03
Biogen USD 18.78B 1.26B 2025-07
BioMarin Pharmaceutical USD 13.56B 1.02B 2025-03
Cytokinetics USD 4.79B 759M 2025-03
Dynavax Technologies USD 1.61B 67M 2025-03
Exelixis USD 12.59B 108M 2025-07
Gilead Sciences USD 139.68B 24.59B 2025-03
Halozyme Therapeutics USD 7.88B 1.8B 2025-03
Incyte USD 17.37B 4.19B 2025-07
Ionis Pharmaceuticals USD 6.05B 1.25B 2025-07
Neurocrine Biosciences USD 13.35B 2.41B 2025-07
Pfizer USD 143.72B 6.63B 2025-03
Prothena USD 745M 155M 2024-12
Regeneron Pharmaceuticals USD 58.9B 10.44B 2025-07
Repligen USD 6.99B 0 2025-07
Sarepta Therapeutics USD 1.71B 4.49B 2025-07
Teva Pharmaceutical Industries ILS 63.18B 838.88M 2025-07
Ultragenyx Pharmaceutical USD 3.4B 485M 2025-03


Neurocrine Biosciences Kapitalizacja Rynkowa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.